Cargando…

New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer

Detalles Bibliográficos
Autores principales:	Prétet, Jean-Luc, Guenat, David, Riethmuller, Didier, Mougin, Christiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078487/ https://www.ncbi.nlm.nih.gov/pubmed/25055395

Ejemplares similares

Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples
por: Guenat, David, et al.
Publicado: (2018)

Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2
por: Guenat, David, et al.
Publicado: (2016)

HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study
por: Baumann, Antoine, et al.
Publicado: (2021)

Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis
por: Guenat, David, et al.
Publicado: (2017)

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
por: Morel, Adrien, et al.
Publicado: (2017)

Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15–23 years
por: Baudu, Ariane, et al.
Publicado: (2014)

Awareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco
por: Belglaiaa, Essaada, et al.
Publicado: (2018)

Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients
por: Molimard, Chloé, et al.
Publicado: (2021)

Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7
por: Aubin, François, et al.
Publicado: (2013)

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial
por: Debernardi, Alice, et al.
Publicado: (2022)

The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression
por: Meznad, Koceila, et al.
Publicado: (2021)

Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism
por: Paget-Bailly, Philippe, et al.
Publicado: (2019)

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
por: Riethmuller, Didier, et al.
Publicado: (2015)

Apoptotic HPV Positive Cancer Cells Exhibit Transforming Properties
por: Gaiffe, Emilie, et al.
Publicado: (2012)

STAT1 expression and HPV16 viral load predict cervical lesion progression
por: Wu, Si, et al.
Publicado: (2020)

Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward – a meeting report
por: Waheed, Dur-e-Nayab, et al.
Publicado: (2023)

Human papillomavirus genotype distribution in tonsil cancers
por: St Guily, Jean Lacau, et al.
Publicado: (2011)

Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020)

Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer
por: Kim, Jongseung, et al.
Publicado: (2020)

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
por: Téguété, Ibrahima, et al.
Publicado: (2017)

Cervical and Oral Screening for HR-HPV types 16 and 18 among Sudanese Women Cervical Lesions
por: Elasbali, Abdelbaset Mohamed, et al.
Publicado: (2012)

HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix
por: Long, Wenbo, et al.
Publicado: (2018)

Tristetraprolin: a weapon against HPV-induced cervical cancer?
por: Gallouzi, Imed-Eddine, et al.
Publicado: (2009)

Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression
por: Liu, Hang, et al.
Publicado: (2022)

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma
por: Sastre-Garau, Xavier
Publicado: (2015)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16
por: Hong, Die, et al.
Publicado: (2017)

Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women
por: Oyervides-Muñoz, Mariel A., et al.
Publicado: (2020)

HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?
por: Landy, Rebecca, et al.
Publicado: (2021)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area
por: Belglaiaa, Essaada, et al.
Publicado: (2015)

Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay
por: Galati, Luisa, et al.
Publicado: (2022)

Exploring Microbiota Diversity in Cervical Lesion Progression and HPV Infection through 16S rRNA Gene Metagenomic Sequencing
por: Stoian, Irina Livia, et al.
Publicado: (2023)

Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
por: Khazaei, Sedigheh, et al.
Publicado: (2016)

At the center of cervical carcinogenesis: synergism between high-risk HPV and the hyperactivated YAP1
por: Wang, Cheng, et al.
Publicado: (2019)

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program
por: Matsumoto, Koji, et al.
Publicado: (2019)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

HPV vaccination bridges to HPV screening
por: Harper, Diane M, et al.
Publicado: (2020)

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions
por: Li, Yuejie, et al.
Publicado: (2019)

Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
por: Vega-Peña, Arianna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s9d4g6j6kqmebcemc246hffp5k